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The Japanese Schizophrenia Sib-Pair Linkage Group (JSSLG) is a multisite collaborative study group that was organ-
ized to create a national resource for affected sib pair (ASP) studies of schizophrenia in Japan. We used a high-
density single-nucleotide–polymorphism (SNP) genotyping assay, the Illumina BeadArray linkage mapping panel
(version 4) comprising 5,861 SNPs, to perform a genomewide linkage analysis of JSSLG samples comprising 236
Japanese families with 268 nonindependent ASPs with schizophrenia. All subjects were Japanese. Among these
families, 122 families comprised the same subjects analyzed with short tandem repeat markers. All the probands
and their siblings, with the exception of seven siblings with schizoaffective disorder, had schizophrenia. After
excluding SNPs with high linkage disequilibrium, we found signiﬁcant evidence of linkage of schizophrenia to
chromosome 1p21.2-1p13.2 ( ) and suggestive evidence of linkage to 14q11.2 ( ), 14q11.2-LODp 3.39 LODp 2.87
q13.2 ( ), and 20p12.1-p11.2 ( ). Although linkage to these regions has received littleLODp 2.33 LODp 2.33
attention, these regions are included in or partially overlap the 10 regions reported by Lewis et al. that passed the
two aggregate criteria of a meta-analysis. Results of the present study—which, to our knowledge, is the ﬁrst
genomewide analysis of schizophrenia in ASPs of a single Asian ethnicity that is comparable to the analyses done
of ASPs of European descent—indicate the existence of schizophrenia susceptibility loci that are common to different
ethnic groups but that likely have different ethnicity-speciﬁc effects.
Introduction
Schizophrenia (MIM 181500) is a common disorder, with
a lifetime morbidity risk of 1%. A large number of fam-
ily, twin, and adoption studies have revealed that indi-
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vidual differences in susceptibility are predominantly
genetic, with a heritability of 0.70–0.85 and a 10-fold
increased risk in siblings of probands (Levinson and
Mowry 2000). More than 20 genome scans for suscep-
tibility loci for schizophrenia have been completed, and
evidence satisfying genomewide signiﬁcance levels for
linkage to schizophrenia was obtained for chromosome
regions 6p24-p22 (MIM 600511) (Straub et al. 1995),
1q21-q22 (MIM 604906) (Brzustowicz et al. 2000),
13q32-q34 (MIM 603176) (Blouin et al. 1998), 10p14
(DeLisi et al. 2002b), and 10q25.3-q26.3 (Williams et
al. 2003). Linkage for other regions—including 8p22-
p21 (MIM 603013) (Kendler et al. 1996; Blouin et al.
1998), 6q21-q25 (MIM 603175) (Cao et al. 1997; Lind-
holm et al. 2001), 22q11-q12 (MIM 600850) (Pulver et
al. 1994; Schizophrenia Linkage Collaborative Group
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for Chromosomes 3 and 8 1996), and 5q21-q33 (MIM
181510) (Bassett et al. 1988; Paunio et al. 2001)—has
been reported multiple times. However, none of the
above-named regions has been identiﬁed consistently in
a majority of the genome scans. It is possible that loci
with small populationwide effects hinder conﬁrmation
of linkage because replication of linkage data requires
a larger sample population than the original data set
(Suarez et al. 1994) and because the samples for most
genome scans of schizophrenia have been small, typically
20–100 families.
Some problems of power and replication can be ad-
dressed by meta-analysis. Lewis and colleagues (2003)
used the rank-based genome-scan meta-analysis (GSMA)
method to analyze 20 complete genome scans for sus-
ceptibility loci for schizophrenia. In GSMA, the auto-
somes were divided into 30-cM bins, and the evidence
of linkage in each study was rank ordered across bins
with and without weights for sample size. The average
ranks across studies were evaluated for statistically sig-
niﬁcant evidence of linkage in several ways. Lewis et al.
(2003) concluded that schizophrenia loci are highly likely
to be present in one or more of the following regions:
1p13.3-q23.3, 2p12-q23.3, 3p25.3-p22.1, 5q23.2-q34,
6pter-p21.1, 8p22-p21.1, 11q22.3-q24.1, 14pter-q13.1,
20p12.3-p11, and 22pter-q12.3, all of which met two
aggregate criteria for linkage. Another meta-analysis
found signiﬁcant results only for chromosomes 8p, 13q,
and 22q (Badner and Gershon 2002). However, meta-
analysis has limitations (Levinson et al. 2003). One is
that meta-analysis methods may not distinguish several
weakly linked loci in the same region. This issue can be
addressed by pooling the raw genotyping data for meta-
analysis. Analysis of a multicenter sample of 779 pedi-
grees did not yield signiﬁcant evidence of linkage of 22q
to schizophrenia (Mowry et al. 2004); however, those
authors suggested that collaborative pooling of data sets
was limited by intersite differences in sampling frames,
population ethnicity, and genotyping methods.
The largest genomewide linkage ﬁndings to date were
reported by DeLisi and colleagues (2002b), who studied
294 families with 382 nonindependent affected sib pairs
(ASPs) with schizophrenia or schizoaffective disorder
from the United States, the United Kingdom, Italy,
Chile, and Belgium. Williams and colleagues (2003) de-
scribed linkage ﬁndings in 272 families with 353 non-
independent ASPs from the United Kingdom, Sweden,
and the United States. Among these ASPs, 287 non-
independent ASPs in 231 families received a diagnosis
of schizophrenia or schizoaffective disorder. Straub and
colleagues (2002) described linkage ﬁndings in 270
families with 261 nonindependent ASPs with schizo-
phrenia or poor-outcome schizoaffective disorder from
Ireland and Northern Ireland. The Irish families were
ethnically homogeneous, and most of the pedigrees in
the other two studies were of European origin. The nar-
row ethnic distributions of these sample populations
could have inﬂuenced the results, because an ethnically
diverse study population has increased potential for var-
iation, which could result in heterogeneity at certain
susceptibility loci. A recent study found ethnic hetero-
geneity between European and East Asian populations
in allelic association of the 102T/C polymorphism of
the HTR2A gene (MIM 182135) with schizophrenia
(Abdolmaleky et al. 2004). This type of heterogeneity
compounds the recognized difﬁculty in characterizing
genetically complex diseases for which the magnitude
of the effect of any one locus is unknown.
The Japanese Schizophrenia Sib-Pair Linkage Group
(JSSLG), a multisite collaborative study group, was es-
tablished in 1997 as a national resource for genetic stud-
ies of schizophrenia. An initial genomewide linkage study
was performed with 417 STR markers in 130 families;
however, no loci with signiﬁcant linkage to schizophre-
nia were detected (JSSLG 2003). We recruited addition-
al families to participate in the JSSLG study and ana-
lyzed 236 families with 268 nonindependent ASPs with
a high-density SNP linkage mapping set. High-density
SNP linkage mapping systems provide signiﬁcantly im-
proved levels of information extraction with extremely
high accuracy, particularly when founder genotypes are
unavailable (Sawcer et al. 2004).
Material and Methods
Subjects
Linkage of genetic loci to schizophrenia was analyzed
in Japanese families with at least two available siblings
who had received the diagnosis of schizophrenia or schi-
zoaffective disorder. A total of 236 families with 602 in-
dividuals were recruited at 24 centers across Japan (table
1). Of these, 122 families with 315 individuals com-
prised the same subjects analyzed by STR markers that
we reported elsewhere (JSSLG 2003). Each family mem-
ber received the diagnosis on the basis of the DSM-IV
structured clinical interview. Each face-to-face interview
was conducted by two experienced interviewers. In ad-
dition to direct interviews, all available medical records
and information from relatives and hospital staff were
considered. Inclusion criteria for this collaborative sam-
ple recruitment were DSM-IV-deﬁned schizophrenia for
probands and schizophrenia or schizoaffective disorder
for affected siblings. Seven siblings with schizoaffective
disorder were included. All participants and their parents
were of Japanese descent. The study protocol was ap-
proved by the ethics committee of each institution, and
written informed consent was obtained from all subjects.
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Table 1
JSSLG Subjects
CENTERa
NO. OF
FAMILIES
NO. OF JSSLG FAMILIES
Both Parentsb One Parentb No Parentb
2
Affected Sibs
3
Affected Sibs
2
Affected Sibs
3
Affected Sibs
2
Affected Sibs
3
Affected Sibs
Hakkaido University 2 0 0 0 0 1 1
Hirosaki University 1 0 0 0 0 0 1
Minami Hanamaki National Hospital 18 5 0 8 0 5 0
Tohoku University 1 0 0 0 0 1 0
Fukushima Medical University 4 0 0 2 0 2 0
Niigata University 19 3 0 2 0 14 0
University of Tsukuba 16 0 0 3 2 10 1
Teikyo University Ichihara Hospital 23 0 0 2 0 21 0
RIKEN Brain Science Institute 7 5 0 2 0 0 0
Juntendo University 3 2 0 1 0 0 0
Toho University 10 0 0 0 0 10 0
Tokyo Institute of Psychiatry 1 0 0 0 0 0 1
Nihon University 11 1 1 0 0 9 0
Teikyo University 4 0 0 2 0 2 0
National Center of Neurology and Psychiatry 5 0 0 0 0 5 0
Fujita Health University 7 0 0 0 0 7 0
Osaka Medical College 4 0 0 0 0 4 0
Okayama University 33 0 0 2 0 27 4
University of Occupational and Environmental Health 10 1 0 0 0 9 0
Kyushu University 2 0 0 0 0 2 0
Kurume University 7 0 0 0 0 7 0
Saga Medical School 22 5 1 5 1 10 0
Nagasaki University 19 7 0 7 1 3 1
Kagoshima University 7 0 1 1 0 5 0
Total 236 29 3 37 4 154 9
a In order of location from north to south.
b Available for genotyping.
Genotyping
The Illumina SNP-based Linkage Panel IV was used for
genotyping. The panel includes 5,861 SNP markers dis-
tributed evenly across the genome. The average and me-
dian intervals between markers were 503 kb (0.64 cM)
and 301 kb (0.35 cM), respectively. The largest interval
between successfully genotyped markers was 4.9Mb (8.8
cM) on chromosome Xp21. The Illumina markers were
typed with the Illumina BeadStation 500G, in accordance
with the manufacturer’s standard recommendations.
Statistical Analysis
Multipoint linkage analysis was performed along the
entire length of each chromosome with the MERLIN
program (Center of Statistical Genetics) developed by
Abecasis et al. (2002). Both the nonparametric linkage
(NPL)Z score and nonparametric LOD score, calculated
with the Kong and Cox (1997) linear model, were ex-
tracted from the MERLIN runs and were used to gener-
ate graphic plots of the whole-genome scan results. Be-
cause linkage disequilibrium (LD) between closely spaced
SNPmarkers can falsely inﬂate linkage statistics, we used
the SNPLINK program (Webb et al. 2005; Institute of
Cancer Research), which removes LD from the marker
sets in an automated fashion. Because the program con-
siders LD between pairs of adjacent SNPs, the possibility
of high LD between nonadjacent SNPs but low LD be-
tween adjacent SNPs, such as a situation in which there
was high LD between SNPs 41 and 43 and low LD be-
tween SNPs 41 and 42 and between SNPs 42 and 43,
was examined with the Haploview program. Because no
empirical justiﬁcation to remove LD by any criteria has
been published, we tested the signiﬁcant and sugges-
tive regions, using a range of criteria from ,2r p 0.4
and gradually decreased the thresholds to .2r p 0.05
The linkage panel includes 28 SNPs from the pseudo-
autosomal regions of the X chromosome (20 from the
short arm; 8 from the long arm). Because no currently
available multipoint linkage program can integrate data
from X-linked and pseudoautosomal markers in a sin-
gle analysis, each pseudoautosomal region was analyzed
separately, as though it were an independent autosomal
chromosome. The results of these analyses were then
combined with those from the standard X-linked mark-
ers. Empirical P values were calculated for the NPL Z
and LOD scores via simulation. MERLIN was used to
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Figure 1 Multipoint nonparametric LOD score (Kong and Cox 1997) of genomewide scan for JSSLG ASPs with schizophrenia
generate 50,000 replicates of families identical to those
in our sample. Markers with similar allele frequencies
were also generated under the assumption of no linkage.
Linkage analyses were then performed on these unlinked
replicates, and peaks of NPL Z and LOD scores sepa-
rated by at least 30 cM on each chromosome were re-
corded for each simulation. Simulation studies of our
genome scan suggested that, on average, an NPL Z of
2.87 and a LOD of 2.06 per genome scan would have
been expected, whereas an NPL Z of 3.48 and a LOD
of 3.07 would have been expected to occur only once
in every 20 genome scans in the absence of linkage.
Therefore, these values correspond to “suggestive” and
“signiﬁcant” thresholds for genomewide signiﬁcance, as
deﬁned by Lander and Kruglyak (1995). TheGeneFinder
program (Liang et al. 2001; Chiu et al. 2002; Glidden
et al. 2003) was used to obtain 95%CIs for the locations
of linked loci. The information content of the genotypes
was estimated by MERLIN, with use of entropy infor-
mation described by Kruglyak et al. (1996). Simulations
suggested that our study had a power of 10.99, 0.79,
0.38, and 0.05 to detect a susceptibility locus of lsp
, 2, 1.5, and 1.25 for schizophrenia, with a genomewide3
signiﬁcance of .Pp .05
Results
Among our Japanese family members, we observed an
average minor-allele frequency of 0.29 and a mean het-
erozygosity of 0.37. These values were identical to those
in Asian populations in the Illumina Linkage IV Panel.
In our Japanese population, 125 SNPs were not poly-
morphic. The call rate (percentage of successful genotype
calls among subjects) was used as a measure of quality.
The average call rate was 98.5%, and we excluded 10
SNPs with call rates of !90%. The rate of Mendelian
inconsistency or impossible recombination identiﬁed by
the MERLIN program was 0.027% in the families with
parents available for genotyping. Because the low het-
erozygosity of SNPs means that only 37% of genotyping
errors will appear as Mendelian inconsistencies (Abe-
casis et al. 2002), the approximate genotyping error rate
was estimated to be 0.073%.
Results of the linkage analysis are presented in ﬁg-
ure 1. One region, 1p21.1, showed genomewide sig-
niﬁcance ( ) on the basis of simulation studiesP ! .05
( ; NPL ) with a 95%CI of 102.0–LODp 3.39 Zp 3.96
111.9 Mb (National Center for Biotechnology Informa-
tion [NCBI] build 35). We also obtained suggestive evi-
dence of linkage to chromosome 14q11.2 (LODp
; NPL ), with a 95%CI of 19.4–34.9Mb;2.87 Zp 3.14
chromosome 14q12 ( ; NPL ),LODp 2.33 Zp 2.95
with a 95% CI of 19.4–34.9 Mb; and chromosome
20p11.2 ( ; NPL ), with a 95%LODp 2.33 Zp 3.10
CI of 16.0–33.2 Mb (table 2). Notable results were
also obtained for chromosomes 4q24 ( ;LODp 1.44
NPL ), 4q31.3 ( ; NPLZp 2.32 LODp 1.44 Zp
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Table 2
Chromosome Regions with Genomewide Signiﬁcant and Suggestive Linkage to Schizophrenia in 268 Nonindependent JSSLG ASPs
Peak SNP
Chromosome
Region
Distance
from pter
Marker
(cM)
Positiona
(Mb) NPL Z (P) LODb (P) 95% CI SNP Regiona
95% CI
Positiona
(Mb)
95% CI
Chromosome
Region
rs2048839 1p21.1 126.18 105.7 3.96 (.00004) 3.39 (.00004) rs1445225–rs575208 102.0–111.9 1p21.2-p13.2
rs1319956 14q11.2 .00 19.4 3.14 (.0009) 2.87 (.0001) rs1319956–rs8904 19.4–34.9 14q11.2-q13.2
rs7149108 14q12 31.14 32.0 2.95 (.002) 2.33 (.0005) rs1319956–rs8904 19.4–34.9 14q11.2-q13.2
rs7988 20p11.2 53.08 23.3 3.10 (.001) 2.33 (.0005) rs775133–rs663550 16.0–33.2 20p12.1-q11.2
a NCBI build 35.
b Calculated with the Kong and Cox (1997) linear model.
), 12q24.3 ( ; NPL ), and2.42 LODp 1.91 Zp 2.67
19p13.3 ( ; NPL ).LODp 1.49 Zp 2.32
Among 5,736 SNPs, 22 pairs of nonadjacent SNPs
were in LD with but no adjacent SNPs were2r 1 0.05
in LD with . However, no such pairs were lo-2r ! 0.05
cated in the signiﬁcant and suggestive regions. The LOD
scores were not changed by decreasing the thresholds
to remove LD in the SNPLINK program, because pairs
of adjacent SNPs showed high LD ( ) or no or2r 1 0.4
very low LD ( ) in these regions.2r ! 0.01
Discussion
In our previous study of 130 families (JSSLG 2003), we
did not observe any signiﬁcant or suggestive evidence of
linkage with schizophrenia. Of the 236 families exam-
ined in the present study, 122 had been analyzed pre-
viously. The present study revealed signiﬁcant and sug-
gestive evidence of linkage of speciﬁc chromosome re-
gions to schizophrenia. The larger number of families
and increased information extracted by the high-density
SNP linkage system used in the present study may have
contributed to the present results. The overall genetic
linkage information content per 3-cM interval increased
from 0.48 in our previous study (JSSLG 2003) to 0.72
in the present study. In addition to the increase in ex-
tractable information, high-throughput DNA typing
technology is advantageous because it is accurate, fast,
and requires little DNA. The genotyping error rate was
∼0.073% in the present study. Although error rates are
rarely published—and when they are expressed, the ter-
minology varies greatly—it is noteworthy that microsat-
ellite error rates of 0.1%–12.7% per reaction have been
reported (Brzustowicz et al. 1993; Ginot et al. 1996;
Ghosh et al. 1997; Ewen et al. 2000; Sobel et al. 2002;
Weeks et al. 2002). Abecasis et al. (2001) reported that
error rates of just 1% can reduce observed LOD scores
by as much as 50%.
Our strongest ﬁnding was signiﬁcant evidence of link-
age of schizophrenia to the region 1p21-p13. To our
knowledge, studies of linkage to schizophrenia have not
focused on linkage to this region. However, this region
overlaps a telomeric part of bin 1.6, which showed evi-
dence of linkage to schizophrenia in the meta-analysis
reported by Lewis et al. (2003) (table 2). A small peak
LOD score for this region was observed in a cohort in
the Central Valley of Costa Rica (DeLisi et al. 2002a).
An NPL score of 2.72 for region 1p21 was observed
in seven families with schizophrenia or schizophrenia
spectrum personality disorders (Pulver et al. 2000). The
NTNG1 gene (MIM 608818) is located on 1p13.3 and
may be a candidate gene for schizophrenia susceptibil-
ity. Association between speciﬁc haplotypes encompass-
ing alternatively spliced exons of NTNG1 and schizo-
phrenia was observed in a Japanese population (Aoki-
Suzuki et al. 2005).
Suggestive evidence of linkage to 14q11.2-q13.2 was
also obtained in the present study. One region with NPL
scores 12.0 in Arab-Israeli families was 14q11.1-q11.2
(Lerer et al. 2003). Potential linkage of schizophrenia
to 14q13 was reported for the Maryland epidemiologic
sample comprising 44 families of European descent
( ; ) (Blouin et al. 1998). A motherNPLp 2.57 Pp .005
and daughter who received the diagnoses of schizo-
phrenia and schizophrenia comorbid with mild learning
disability, respectively, possessed a balanced reciprocal
translocation t(9,14)(q34.2;q13), and the NPAS3 gene
(MIM 609430) on 14q13.1 (32.5–33.3 Mb) was dis-
rupted (Kamnasaran et al. 2003; Pickard et al. 2005).
The region of 14q11.2-q13.2 is included in bin 14.1,
which showed evidence of linkage in the meta-analysis
reported by Lewis et al. (2003) (table 2).
Suggestive evidence of linkage to 20p11.2 was also
obtained in the present study. Linkage of 20p11 with
bipolar disorders has been reported (Radhakrishna et
al. 2001; McInnis et al. 2003). This region is included
in bin 20.2, which showed evidence of linkage with
schizophrenia in the meta-analysis reported by Lewis et
al. (2003) (table 2).
In the present study, all of the regions that showed
signiﬁcant and suggestive evidence of linkage to schizo-
phrenia are included in or partially overlap the 10 re-
gions that passed the two aggregate criteria of a meta-
analysis (Lewis et al. 2003), although these regions have
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not received much attention (Owen et al. 2004). There-
fore, the presence of susceptibility loci for schizophrenia
in both European and Asian populations in these re-
gions is plausible, although these loci may have larger
populationwide effects on schizophrenia in Asian popu-
lations than in European populations. Additional larger
studies of Asian populations might validate the hypothe-
sis (Hwu et al. 2005). In conclusion, the present JSSLG
linkage study of Japanese families—which is one of the
largest genomewide ASP analyses of a single ethnicity
for schizophrenia to date and is comparable to genome-
wide ASP analyses of families of European descent with
schizophrenia—supports the existence of schizophrenia
susceptibility loci common to different ethnic groups but
with possible ethnic-speciﬁc effects.
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